| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K61166597 |
| PharmacoGx | BRD-K61166597 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBR1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | ZMYM3 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | TXLNG | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | LTBP2 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | CCDC88C | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | FCHSD1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | GABRA5 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | ERVMER34-1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | SEC24D | CTRPv2 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | MSL1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.005 |
